PT  - JOURNAL ARTICLE
AU  - Bärwolff, Günter
TI  - COVID-19 propagation by diffusion - a two-dimensional approach for Germany
AID  - 10.1101/2021.01.15.21249893
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.15.21249893
4099  - http://medrxiv.org/content/early/2021/01/20/2021.01.15.21249893.short
4100  - http://medrxiv.org/content/early/2021/01/20/2021.01.15.21249893.full
AB  - Diffusion comes anytime and everywhere. If there is a gradient or a potential difference of a quantity a diffusion process happens and this ends if an equilibrium is reached only. The concentration of a species maybe such quantity, or the voltage. An electric currant will be driven by a voltage difference for example.In this COVID-19 pandemic one observes both regions with low incidence and other ones with high incidence. The local different people density could be a reason for that. In populous areas like big cities or congested urban areas higher COVID-19 incidences could be observed than in rural regions.The aim of this paper consists in the application of a diffusion concept to describe one possible issue of the the COVID-19 propagation.This will be discussed for the German situation based on the quite different incidence data for the different federal states of Germany.With this ansatz some phenomenoms of the actual development of the pandemic could be confirmed. The model gives a possibility to investigate certain scenarios like border-crossings or local spreading events and their influence on the COVID-19 propagation as well.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no founding of this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no approval necessary, it is a theoretic mathematical model about the COVID-19 pandemicAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll used data are available on open websites. https://www.rki.de/DE/Home/homepage_node.html